thymic-factor--circulating and Osteomyelitis

thymic-factor--circulating has been researched along with Osteomyelitis* in 2 studies

Other Studies

2 other study(ies) available for thymic-factor--circulating and Osteomyelitis

Article	Year
[Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications]. Khirurgiia, 1996, Issue:2 The influence of immunoactive medicines on the cell immunity have been studied. There were differences in reaction to T-activin and Thymalin between various patients with septic postoperative complications. Thymalin stimulated T-cells while acting with immunoglobulins or immune plasmas only. T-activin led to the increase in the number of T-lymphocytes and B-lymphocytes independently of it's cooperation with the vaccines. The stimulating effect of myelopid demonstrated itself by increase in the number of B-lymphocytes and immunoglobulins M and G after 14 days of treatment. The positive clinical effect was more impressive when immunomodulators were used in combinations with the vaccines; still it did not correlate completely with the dynamics of the cell immunity parameters. Topics: Activins; Adjuvants, Immunologic; Bone Marrow; Empyema, Pleural; Humans; Immunoglobulins; Lymphocyte Subsets; Oligopeptides; Osteomyelitis; Peptides; Peritonitis; Phagocytosis; Postoperative Complications; Suppuration; Surgical Wound Infection; Thymus Extracts; Thymus Hormones; Time Factors	1996
[Clinico-experimental basis for using thymalin in osteomyelitis and suppurative-inflammatory diseases of soft tissues in children]. Pediatriia, 1983, Issue:9 Topics: Adjuvants, Immunologic; Adolescent; Animals; Cellulitis; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Osteomyelitis; Rats; Staphylococcal Infections; Thymus Hormones	1983

Article

Year

[Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications].

Khirurgiia, 1996, Issue:2

The influence of immunoactive medicines on the cell immunity have been studied. There were differences in reaction to T-activin and Thymalin between various patients with septic postoperative complications. Thymalin stimulated T-cells while acting with immunoglobulins or immune plasmas only. T-activin led to the increase in the number of T-lymphocytes and B-lymphocytes independently of it's cooperation with the vaccines. The stimulating effect of myelopid demonstrated itself by increase in the number of B-lymphocytes and immunoglobulins M and G after 14 days of treatment. The positive clinical effect was more impressive when immunomodulators were used in combinations with the vaccines; still it did not correlate completely with the dynamics of the cell immunity parameters.

Topics: Activins; Adjuvants, Immunologic; Bone Marrow; Empyema, Pleural; Humans; Immunoglobulins; Lymphocyte Subsets; Oligopeptides; Osteomyelitis; Peptides; Peritonitis; Phagocytosis; Postoperative Complications; Suppuration; Surgical Wound Infection; Thymus Extracts; Thymus Hormones; Time Factors

1996

[Clinico-experimental basis for using thymalin in osteomyelitis and suppurative-inflammatory diseases of soft tissues in children].

Pediatriia, 1983, Issue:9

Topics: Adjuvants, Immunologic; Adolescent; Animals; Cellulitis; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Osteomyelitis; Rats; Staphylococcal Infections; Thymus Hormones

1983